drugset / Trial / NCT01679574

Letrozole or Combined Clomiphene Citrate Metformin as a First Line Treatment in Women With Polycystic Ovarian Syndrome

NCT01679574

Completed 200 enrolled Assiut University
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare and determine the efficacy of letrozole administration to that of combined metformin and Clomiphene in infertile women with polycystic ovary syndrome (PCOS) not treated before with any ovulation induction agent

Timeline

Start
2009-01
Primary completion
2012-01
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clomiphene Other / unclassified 50 mg Oral
Subject Letrozole Other / unclassified 2.5 mg Oral
Subject Letrozole Other / unclassified 5 mg Oral
Comparator Metformin Small molecule 500 mg Oral